|
Volumn 4, Issue 2, 2005, Pages 70-
|
Treatment of emotional lability in ALS
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AVP 39;
DEXTROMETHORPHAN;
GABAPENTIN;
GLUTAMATE RECEPTOR;
GLUTAMATE RECEPTOR ANTAGONIST;
LAMOTRIGINE;
NITRIC OXIDE SYNTHASE;
QUINIDINE SULFATE;
RILUZOLE;
TOPIRAMATE;
AMYOTROPHIC LATERAL SCLEROSIS;
CLINICAL TRIAL;
CRYING;
DISEASE EXACERBATION;
DORSAL RAPHE NUCLEUS;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
HUMAN;
MENTAL INSTABILITY;
NAUSEA;
NONVERBAL COMMUNICATION;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PSEUDOBULBAR PALSY;
SCORING SYSTEM;
SHORT SURVEY;
SIDE EFFECT;
SOMNOLENCE;
WEIGHT REDUCTION;
|
EID: 12344274544
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(05)00970-1 Document Type: Letter |
Times cited : (12)
|
References (6)
|